BRIEF-Transgene to continue phase 1/1b study in chronic hepatitis B patients

* Transgene to continue phase 1/1b study with TG 1050 in

chronic hepatitis B patients on the recommendation of the

trial's safety review committee

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

Read more